[August 25, 2016] |
|
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025 - Research and Markets
Research and Markets has announced the addition of the "Top
25 Pharmaceutical Company Pipeline Analysis and Sales Projections to
2025" report to their offering.
The report "Top 25 Pharmaceutical Company Pipeline Analysis and Sales
Projections to 2025" examines the leaders in the pharmaceutical
industry, including the late-term pipeline of major companies. This
report provides long-term company sales forecasts based recent market
conditions.
For each company covered, the report provides:
-
Corporate Summary
-
Total Company Revenue and Total R&D Spending 2011-2015
-
Break-up of Sales by Region, 2015
-
Pharmaceutical Business Performance, 2011-2015 and Forecasted 2025
-
Pharmaceutical Segment Sales, 2011 through 2015 and Forecasted 2025
-
Leading Pharmaceutical Products, 2015 Sales
-
Late Stage Product Pipeline
-
Late Stage Product Pipeline by Therapeutic Area, Comparing 2009, 2011,
2013 and 2015
-
Corporate Development Details
The companies covered in this study include:
-
Pfizer
-
Novartis
-
Roche
-
Merck
-
Sanofi and 20 more
Top 25 Pharmaceutical Company Pipeline Analysis and Sales
Projections to 2025 provides a thorough discussion of current trends in
pharmaceutical research and development, including:
-
Pharmaceutical Research & Development Challenge
-
The Drug Approval Process
-
Expanded Options in Treating Diseases
-
Biotechnology Drug Development
-
Orphan Drugs
-
Fast Track Drug Status
-
Other Accelerated Methods for Drug Approval
-
Pharmaceutical Regulatory Exclusivity
-
The Role of Contract Research Organizations
In addition to its company focus, the report examines the global
pharmaceutical market, which has continued its recovery from the
economic downfall experienced in recent years. Healthcare costs as a
percent of GDP are increasing in almost all countries, though there are
some exceptions. There are a number of macroeconomic concerns affecting
sales such as aging populations, incidence of disease, unmet medical
needs, government activities, and more.
Data provided include:
-
Global Pharmaceutical Projects in Development by Therapeutic Segment
-
Global Pharmaceutical Market, 2011-2015 and Forecasted 2025
-
Global Pharmaceutical Market by Therapeutic Area, 2011-2015 and
Forecasted 2025
-
Total Healthcare Expenditures as a Percent of GDP by Country 2010 and
2015 Estimates (Australia, Austria, Canada, Czech Republic, Finland,
France, Germany, Greece, Italy, Japan, Mexico, Switzerland, United
Kingdom, United States)
-
International Population Trend Age 65+
For more information about this report visit http://www.researchandmarkets.com/research/5tjnq3/top_25
Related Topics: Pharmaceuticals
View source version on businesswire.com: http://www.businesswire.com/news/home/20160825005500/en/
[ Back To TMCnet.com's Homepage ]
|